June 26, 2006Circulation
Vascular Biomarkers and Surrogates in Cardiovascular Disease
Key result
Cardiovascular biomarkers play a critical role in advancing therapies, evaluating early efficacy and safety, and supporting clinical applications in cardiovascular disease drug development.
Design
Review
Authors
Discussion
Loading...
Member takes
Implication
Biomarkers may streamline early CV drug evaluation; leaves open standardized thresholds for regulatory and clinical adoption.
PICO
P
Population
Cardiovascular disease
I
Intervention / Comparator
Cardiovascular biomarkers
Highlights the importance of cardiovascular biomarkers in drug development and clinical applications, emphasizing the need for open communication among researchers, developers, and regulators.
Cite This Study
Tardif et al. (2006) conducted a review in Cardiovascular disease. Cardiovascular biomarkers was evaluated. Cardiovascular biomarkers play a critical role in advancing therapies, evaluating early efficacy and safety, and supporting clinical applications in cardiovascular disease drug development.